G. Kraaij

European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC

P. Gisondi, K. Papp, K. Reich, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Methods report: European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC

P. Spuls, M. Wakkee, A. Nast, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

The validity, reliability and acceptability of the SAVASI; a new self‐assessment score in vitiligo

A. Wolkerstorfer, M. A. Rie, G. Kraaij, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians

E. Smets, P. Spuls, F. Vermeulen, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three‐year follow‐up data of a single‐blind randomized controlled trial

E. Prens, T. Rispens, J. Reek, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017

E. D. De Jong, E. Prens, H. Thio, 2019, The British journal of dermatology.